Yes, irritability is a recognized migraine symptom
Irritability is a well-documented symptom of migraine, occurring primarily during the premonitory (pre-headache) phase but also during other phases of the migraine cycle. 1
Evidence from Clinical Research
The most comprehensive recent evidence comes from the 2025 MiCOAS qualitative study, which found that irritability/impatience was reported by 83% of migraine patients across all phases of the migraine cycle, making it one of the five most common symptoms after head pain, light sensitivity, nausea, and sound sensitivity 1. This positions irritability as a cardinal feature of migraine that extends beyond the traditional diagnostic criteria.
Timing and Clustering of Irritability
Premonitory phase: Irritability appears as a warning symptom before headache onset. In a Chinese multi-clinic study of 4,821 patients, mood change/irritability clustered together as paired premonitory symptoms, suggesting they share similar neurobiological origins 2
During attacks: Irritability was significantly more common in patients who experienced repetitive yawning during migraine attacks (21.4% vs 11.4%, p=0.019), suggesting shared dopaminergic-hypothalamic mechanisms 3
Interictal period: Notably, 73% of patients reported symptoms between attacks, including mood/emotion symptoms like irritability, challenging the notion that migraine is purely episodic 1
Clinical Significance
A 2017 symptom-based analysis found that irritability experienced "nearly every day" increased migraine risk substantially (OR 22.0,95% CI 5.7-84.9) 4. This demonstrates that irritability is not merely an incidental finding but a clinically meaningful marker of migraine pathophysiology.
Important Clinical Caveats
While the major international guidelines 5, 6 focus on diagnostic criteria that emphasize pain characteristics and cardinal symptoms (photophobia, phonophobia, nausea/vomiting), they do not explicitly list irritability in their formal diagnostic criteria. However, this represents a gap between guideline criteria and patient-reported reality rather than evidence against irritability as a migraine symptom.
The 2006 prospective study found that premonitory symptoms like irritability were quite consistent across attacks—more than half of premonitory symptoms repeated in at least two out of three attacks 7. This consistency supports using irritability as a clinical marker for early intervention.
Practical Application
Recognize irritability as a valid target for early treatment. When patients report irritability as a premonitory symptom, this represents an opportunity for early acute therapy, which all guidelines recommend 5, 6. The presence of irritability should strengthen clinical suspicion for migraine, particularly when accompanied by other premonitory symptoms like yawning, fatigue, or concentration difficulties.